Advertisement
Advertisement

NGEN

N

NervGen Pharma Corp. Common stock

2.00
USD
Sponsored
-0.06
-3.12%
Jun 16, 15:59 UTC -4
Closed
exchange

Pre-Market

1.94

-0.06
-2.95%

NGEN Earnings Reports

Positive Surprise Ratio

NGEN beat 1 of 1 last estimates.

100%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

NervGen Pharma Corp. Common stock earnings per share and revenue

On May 14, 2026, NGEN reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.05 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
X-Energy, Inc. Class A Common Stock
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.41
Surprise
-623.10%
logo
MiniMed Group, Inc. Common Stock
Report Date
Jun 03, 2026 For Q4 26
Estimate
-$0.17
Actual
-$0.68
Surprise
-291.93%
FAQ
For Q1 2026, NervGen Pharma Corp. Common stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for --.
Based on -- analysts, NervGen Pharma Corp. Common stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement